140 related articles for article (PubMed ID: 2470117)
21. In vivo and ex vivo inhibitory effects of loratadine on histamine release in patients with allergic rhinitis.
Miadonna A; Cottini M; Milazzo N; Tosi D; Danzig M; Tedeschi A
Allergy; 1998 Dec; 53(12):1183-8. PubMed ID: 9930595
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic regulation of antigen-induced mediator release from canine lung.
Krell RD; Chakrin LW
Int Arch Allergy Appl Immunol; 1978; 56(1):39-47. PubMed ID: 73521
[TBL] [Abstract][Full Text] [Related]
23. The effects of astemizole, cetirizine and loratadine on the time course of weal and flare reactions to histamine, codeine and antigen.
Humphreys F; Hunter JA
Br J Dermatol; 1991 Oct; 125(4):364-7. PubMed ID: 1683252
[TBL] [Abstract][Full Text] [Related]
24. [Loratadine inhibits mediator liberation from a suspension of human pulmonary mast cells].
Peters SP
Allerg Immunol (Paris); 1991 Mar; 23(3):109. PubMed ID: 1712595
[No Abstract] [Full Text] [Related]
25. Suppressive effect of loratadine on allergen-induced histamine release in the nose.
Andersson M; Nolte H; Baumgarten C; Pipkorn U
Allergy; 1991 Oct; 46(7):540-6. PubMed ID: 1724592
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A inhibits the release of histamine and peptide leukotriene C4 from human lung mast cells.
Marone G; Triggiani M; Cirillo R; Giacummo A; Siri L; Condorelli M
Ric Clin Lab; 1988; 18(1):53-9. PubMed ID: 2453912
[TBL] [Abstract][Full Text] [Related]
27. Effect of loratadine on immediate and delayed type hypersensitivity reactions.
Tasaka K; Kamei C; Akagi M; Mio M; Izushi K; Yoshida T; Nakamura S
Arzneimittelforschung; 1995 Jul; 45(7):796-804. PubMed ID: 8573225
[TBL] [Abstract][Full Text] [Related]
28. Effect of cinnarizine on IgE antibody-mediated experimental allergic reactions in guinea pigs.
Nagai H; Yamada H; Yakuo I; Inagaki N; Choi SH; Koda A; Daikoku M
Allergy; 1987 Feb; 42(2):135-40. PubMed ID: 2438961
[TBL] [Abstract][Full Text] [Related]
29. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
30. Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187.
Conroy MC; Orange RP; Lichtenstein LM
J Immunol; 1976 Jun; 116(6):1677-81. PubMed ID: 58045
[TBL] [Abstract][Full Text] [Related]
31. The effects of tumour necrosis factor alpha on mediator release from human lung.
Hughes JM; Stringer RS; Black JL; Armour CL
Pulm Pharmacol; 1995 Feb; 8(1):31-6. PubMed ID: 8535096
[TBL] [Abstract][Full Text] [Related]
32. Oxatomide: inhibition and stimulation of histamine release from human lung and leucocytes in vitro.
Church MK; Gradidge CF
Agents Actions; 1980 Apr; 10(1 Pt 2):4-7. PubMed ID: 6155772
[TBL] [Abstract][Full Text] [Related]
33. A comparative study on the release of leukotrienes and histamine by guinea pig lung and trachea after challenge with antigen or stimulation with ionophore A23187 or melittin.
Salari H
Clin Exp Immunol; 1987 Jan; 67(1):211-9. PubMed ID: 3040307
[TBL] [Abstract][Full Text] [Related]
34. Antiallergic activity of loratadine: inhibition of leukotriene C4 release from human leucocytes.
Miadonna A; Milazzo N; Lorini M; Marchesi E; Tedeschi A
Clin Exp Allergy; 1995 Apr; 25(4):364-70. PubMed ID: 7541309
[TBL] [Abstract][Full Text] [Related]
35. Slow reacting substance of anaphylaxis (SRS-A) release from guinea-pig lung parenchyma during antigen- or ionophore-induced contraction.
Fleisch JH; Haisch KD; Spaethe SM
J Pharmacol Exp Ther; 1982 Apr; 221(1):146-51. PubMed ID: 6801255
[TBL] [Abstract][Full Text] [Related]
36. Effect of AS-35 on agonist-induced contractions and the resting tonus of airway smooth muscles and the in vitro release of chemical mediators from passively sensitized lung fragments from humans and guinea pigs.
Watanabe-Kohno S; Yasui K; Ohkawa E; Yamamura H; Horiba M; Inoue K; Ohata K
Jpn J Pharmacol; 1992 Jun; 59(2):227-33. PubMed ID: 1279252
[TBL] [Abstract][Full Text] [Related]
37. Human lung tissue and anaphylaxis: the effects of histamine on the immunologic release of mediators.
Kaliner M
Am Rev Respir Dis; 1978 Dec; 118(6):1015-22. PubMed ID: 84541
[TBL] [Abstract][Full Text] [Related]
38. Release of slow-reacting substance of anaphylaxis from dispersed pig lung cells: effect of cyclo-oxygenase and lipoxygenase inhibitors.
Paterson NA; Burka JF; Craig ID
J Allergy Clin Immunol; 1981 Jun; 67(6):426-34. PubMed ID: 6809801
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation.
Togias AG; Naclerio RM; Warner J; Proud D; Kagey-Sobotka A; Nimmagadda I; Norman PS; Lichtenstein LM
JAMA; 1986 Jan; 255(2):225-9. PubMed ID: 2416958
[TBL] [Abstract][Full Text] [Related]
40. Azelastine inhibits stimulated histamine release from human lung tissue in vitro but does not alter cyclic nucleotide content.
Little MM; Wood DR; Casale TB
Agents Actions; 1989 Aug; 28(1-2):16-21. PubMed ID: 2476920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
